Sk Biopharmaceuticals

Developer of therapeutics to treat CNS disorders

placeSeongnam-si, Gyeonggi-do, South Korea calendar_todayFounded 1993 language skbp.com

Social engagement

Social engagement: 13.9K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%

Recent activity

7 May 2026
Milestone
regulatory
Coming soon